# The Effect of GLP-1 Agonist in Patients With Hypothalamic Obesity: Prospective, Pilot Study

> **NCT06217848** · EARLY_PHASE1 · UNKNOWN · sponsor: **Seoul National University Hospital** · enrollment: 50 (estimated)

## Conditions studied

- Panhypopituitarism
- Craniopharyngioma
- Hypothalamic Obesity

## Interventions

- **DRUG:** Saxenda

## Key facts

- **NCT ID:** NCT06217848
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-11-28
- **Primary completion:** 2024-02-08
- **Final completion:** 2024-03-08
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2024-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06217848

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06217848, "The Effect of GLP-1 Agonist in Patients With Hypothalamic Obesity: Prospective, Pilot Study". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT06217848. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*